Simpson Thacher Sustainability and ESG: Regulatory Update – April 2026
Simpson Thacher Sustainability and ESG: Regulatory Update – April 2026 April 15th, 2026
Saratoga’s Oberbeck: The Fed’s moves have put BDCs in a good spot
Chris Oberbeck, chairman and chief executive officer at Saratoga Investment Corp. -- one of the industry's largest publicly traded business-development companies -- says that BDCs have been a relative sweet spot during this year's troubled times largely because...
John Cole Scott goes discount shopping for Black Friday
With holiday shopping bargains on everyone's mind, John Cole Scott, chief investment officer at Closed-End Fund Advisors -- the chairman of the Active Investment Company Alliance -- sorts through the big discounts in the closed-end fund world to come up with the best bargains...
First Trust’s Grayson: Interval funds are a way to zig against the market’s zag
Michael Grayson, portfolio manager for First Trust Capital Management -- where he oversees their Alternative Opportunities, Private Credit and Real Assets funds -- says that investors should be sacrificing some liquidity for the flexibility to get different assets into their portfolios...
CEF Performance Stabilizes in Q2, Munis Rock the Boat
The universe of closed-end funds (CEFs) saw discounts and yield stay roughly in line with the previous quarter, averaging a -4.74% discount and a weighted yield of 8.8%, said John Cole Scott, AICA Chairman and President of Closed-End Fund Advisors (CEF Advisors), during his firm’s 54th consecutive quarterly research call covering the CEF and business development company (BDC) universe.
Aberdeen’s Akus on the struggles facing healthcare, biotech investors
Jason Akus, Head of Healthcare Investing for Aberdeen Investments, says that current conditions for healthcare and biotech investing are making for "one of the most challenging, difficult and dislocated environments I've seen." While trades in technology, artificial intelligence and...


